Eidam Management Team   Bernard Armani President & Chief Executive Officer As the founder of Eidam Diagnostics Corporation, Bernard Armani brings over 25 years of experience in the natural health industry in Germany and Switzerland to his working relationship with partners in Asia, Europe and North America. Mr. Armani has an extensive background in botanical extraction, oncology, and international trade. Mr. Armani is also the founder of Dermamed™ Pharmaceutical Inc., and BioLytical Laboratories Inc. In 2005, he received the Entrepreneur of the Year Award from the Richmond Chamber of Commerce (Richmond, BC). Dr. Michael Kalden, MD Chief Scientific Officer Dr. Kalden is a specialist in the field of oncology and holistic cancer therapy, and has held numerous appointments with leading medical institutions in Germany. Dr. Kalden has used the CRT 2000® Thermographic System as a core part of his cancer detection and treatment monitoring protocol for over 10 years. His areas of expertise also include naturopathy and pain control. Dr. Kalden is presently the head physician and medical director for the Veramed Hospital at Tannenberg Hospital, which specializes in holistic cancer therapy. He has held this position since 1989. In addition, he has been the co-founder of the Society of Biological Medicine Inc. in Berlin-Meschede and he has headed studies at the Mibeg-Institute, in Cologne, Germany. Recently, Dr. Kalden has opened a new private surgery center for oncology and naturopathy in the Dortmund Center for Hyperthermia and continues his co-operation with the Panacea Center for Preventative Medicine and Research in Vancouver, BC, Canada. As Chief Scientific Officer of Eidam Diagnostics, Dr. Kalden is responsible for the continuing development of and medical validity of the CRT 2000® Thermographic System. Phil Chang Chief Operating Officer Mr. Chang led the team that developed the current client software, including the German and Chinese editions, and engineered the server application architecture. As COO, he is responsible for the development, manufacture and fulfillment of the CRT 2000 product. Mr. Chang has an extensive background in business administration, contract negotiation, and technology implementation. He has worked closely with major corporations in the Canadian forestry and airline industries in developing mission critical tools, workflow processes, and software solutions. In addition, Mr. Chang has held senior management positions, including CEO of Dermamed™ Pharmaceutical Inc., and CFO of BioLytical Laboratories, where he helped the company through successful clinical trials of its flagship HIV rapid diagnostic, and later its sale and ownership transaction. Jeremy Tomlinson Chief Corporate Development Officer As a seasoned entrepreneur and corporate executive Mr. Tomlinson brings extensive experience in operations, international business development, corporate finance and the restructuring of publicly traded companies. Mr. Tomlinson also has extensive mechanical engineering experience in Systems Engineering Management, project management and product development. Mr. Tomlinson has served as: member of the International Standards Organization (ISO) TC197 technical committee; advisor to the South African Department of Science and Technology and serves as director on the boards of both public and private companies. Mr. Tomlinson is responsible for strategic planning and corporate development. Shelley Leonhardt Senior Vice President Shelley Leonhardt brings to Eidam a wealth of public sector experience serving the citizens of British Columbia through Board positions at organizations including the British Columbia Chamber of Commerce, the Tourism Richmond Board of Directors, the Gateway Theatre Board of Directors, and the British Columbia Chamber Executives Board. During her twenty-five year career, Ms. Leonhardt has worked with a wide variety of industry professionals, municipal and provincial officials, and Chamber Executives throughout Canada and the United States to promote and develop both corporate and community interests of British Columbia. During her tenure as Executive Director of The Richmond Chamber of Commerce between 1993 and 2001, the organization was awarded Chamber of the Year in British Columbia. In 1998, Ms. Leonhardt received Richmond, B.C.'s highly prestigious Business Woman of the Year award and was nominated for Richmond's Marketer of the Year and Influential Woman in Business awards. In 1998, Ms. Leonhardt graduated from the Canadian Institute of Organizational Management, University of Western Ontario, The Richard Ivey School of Business (London, Ontario, Canada). Barry Fitzgerald Vice President, Research & Development Mr. Fitzgerald brings over 15 years combined experience in product development, manufacturing, and business operations to his role of Vice President of Research & Development. In this capacity, Mr. Fitzgerald is responsible for product development, manufacturing, and quality assurance, and will focus on rapidly commercializing new products from development through to full-scale manufacture. Throughout his career, Mr. Fitzgerald has also been instrumental in addressing product design and manufacturability issues on complex products, and achieving significant bottom line results, and worked with technology suppliers worldwide to address product and business requirements. In Canada, Mr. Fitzgerald has worked in manufacturing engineering and operations management for complex OEM products. Most recently, Mr. Fitzgerald was a Director, Supply Change Management, for a Class 3 medical device at Xillix Corp., and was an Operations Manager at Creo Inc. (now Kodak's Graphic Communications Division). He also spent three years in product development at Yazaki Corporation in Japan and Europe. He earned an MBA with specialization in management of technology from Simon Fraser University in 2004, and a Bachelor's degree in Production Engineering from the University of Limerick, Ireland, in 1991. Dr. Sven Richardt Vice President, European Operations Dr. Richardt is responsible for Eidam Diagnostics Corporation's European sales and research efforts. A dentist by profession, he has worked with laboratory diagnosis and early detection of disease, including HIV, since 1992.